A groundbreaking study conducted by Professor Jiyoung Park and her research team in the Department of Biological Sciences at UNIST has identified FAM3C, a metabolism-regulating signaling molecule produced by cancer-associated adipocytes (CAAs), as a key regulator of breast cancer progression within the tumor microenvironment (TME).
Pfizer starts $1.5bn cost-cutting initiative amidst declining Covid-19 revenues – Pharmaceutical Technology
The sales for Pfizer’s Covid products, Comirnaty and Paxlovid, decreased by 88% and 50% respectively in Q1 this year, compared to Q1 2022, as per
May 23, 2024